Participants are monitored continuously by highly trained investigators and staff. Subject compliance and symptoms assessment are accurate and reproducible.
Our experienced team of principal investigators and clinicians are actively involved in the protocol design and conduct of all chamber studies.
Biogenics Research Chamber is ideal for proof of concept, dose ranging, mechanisms of action, and efficacy studies evaluating allergic rhinoconjunctivitis and asthma.
Our large database of more than 6,000 potential study subjects and close cooperation with local academic investigators with expertise in molecular biology and genetics, allows us to perform studies at the leading edge of scientific discovery and design.
